24+ years in glycobiology and the M6P pathway
We bring scientific strategy and dedicated program stewardship to every rare disease program we work on.
Glyko Consulting has spent over two decades working at the intersection of glycobiology, enzyme replacement therapy, and rare disease drug development. We work with biotech companies, foundations, and research institutions to guide programs through regulatory pathways, coordinate multi-stakeholder efforts, and build strategies that move therapies closer to patients.
Grant writing (EIC/Horizon, SBIR), study design, regulatory pathway navigation, and IND-enabling program oversight.
Full program management across multi-partner collaborations, milestone tracking, and team coordination.
Foundation engagement (ForeBatten, Lost Enzyme), patient organization strategy, and advocacy-driven development plans.
Custom engagements available
Our regulatory and scientific experience covers the full drug development lifecycle, from preclinical study design through IND filing and beyond. We turn complexity into clear, actionable strategy.
Let's discuss how we can accelerate your program.
We typically respond within 24 hours.